.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Inflammation

Use of Biologics for the Treatment of Asthma panelists

Recommended Guidelines and Restrictions in Asthma

Defining the recommended guidelines and the formulary restrictions with the standard of care for asthma.

The Use of Biologics for the Treatment of Asthma panel

Pharmacologic Treatment Options and Challenges in Asthma

Panelists review the traditional pharmacologic treatment options for asthma and the challenges with them

Examining Unmet Needs in the Management of Eosinophilic Esophagitis

There remains an unmet need for long-term management options for eosinophilic esophagitis, which is associated with a diminished quality of life.

Increased Weight Worsens Bronchial Patency in Children, Study Finds

December 1st 2021, 8:15pm

Article

The trend was true when investigators used body mass index to classify weight, and when measures such as relative body mass index and percentage of body fat were used.

Study Finds Link Between Thalassemia, Risk of Asthma

November 26th 2021, 5:30pm

Article

The study showed children with thalassemia had a greater risk of both atopic and non-atopic asthma.

Survey: Adults With Asthma Routinely Underestimate Severity of Their Cases

November 22nd 2021, 7:00pm

Article

The report, based on a survey conducted in Spain, suggests patients are suffering from additional asthma exacerbations due to a lack of understanding of their disease.

Secondhand Smoke Leads to Respiratory Disease, Even in Adulthood

November 15th 2021, 7:48pm

Article

As many as 4% of population-level asthma cases could be attributed to secondhand smoke, the study suggests.

Research Into Plasma Proteins Yields Potential Biomarkers for Asthma Severity

November 9th 2021, 6:05pm

Article

The analysis showed biomarkers that persisted despite the presence or absence of type-2 inflammation.

Depression Doubles Health Care Costs for Patients With Respiratory Conditions

November 1st 2021, 8:45pm

Article

The analysis found 20% of people with asthma, emphysema, or chronic bronchitis also have depression.

Patients in Risankizumab Phase 2a Trial Saw Some Asthma Symptoms Increase

October 27th 2021, 9:00pm

Article

Risankizumab, a biologic, is used for psoriasis, but whether it can improve asthma control has been unclear.

Combinations of Air Pollutants Linked With Adverse Childhood Asthma Outcomes

October 22nd 2021, 1:30pm

Article

Twenty combinations of toxic pollutants were identified by a machine learning algorithm as being tied with asthma outcomes.

FDA Approves Dupilumab for Children Aged 6 to 11 With Moderate to Severe Asthma

October 20th 2021, 10:05pm

Article

Sold under the name Dupixent, dupilumab is a biologic that inhibits interleukin (IL)-4 and IL-13, which are key drivers of the type 2 inflammation that plays a major role in asthma, chronic rhinosinusitis with nasal polyps, atopic dermatitis, and eosinophilic esophagitis.

Tonya Winders Talks About the Daily Impact of Asthma Guidelines for Patients

October 20th 2021, 10:30am

Video

Future asthma guidelines need to focus more on the unmet needs of the patients whose severe asthma is not well controlled, said Tonya Winders, MBA, CEO and president of the Allergy & Asthma Network.